Merck Closes $1.1B Sirna Acquisition After RNAi Shop Tentatively Settles Three Lawsuits
January 04, 2007
Merck Closes $1.1B Sirna Acquisition After RNAi Shop Tentatively Settles Three Lawsuits
By Doug Macron
The firms closed the deal after Sirna was able to tentatively settle a trio of shareholder-led lawsuits seeking to block the acquisition. The suits accused Sirna brass of double-dealing in their negotiations with Merck.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.